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The antimicrobial properties of copper have been recognized for several years; applying
these properties to the prevention of diseases such as bovine mastitis is a new area of
research. The aim of the present study was to evaluate in vitro the antimicrobial activity
of copper on bacteria isolated from subclinical and clinical mastitis milk samples from
two regions in Chile. A total of 327 microorganisms were recovered between March
and September 2013, with different prevalence by sample origin (25 and 75% from the
central and southern regions of Chile, respectively). In the central region, Escherichia
coli and coagulase negative Staphylococci (CNS) were the most frequently detected in
clinical mastitis cases (33%), while in the southern region S. uberis, S. aureus, and CNS
were detected with frequencies of 22, 21, and 18%, respectively. Antibiotic susceptibility
studies revealed that 34% of isolates were resistant to one or more antibiotics and the
resistance profile was different between bacterial species and origins of isolation of the
bacteria. The minimum inhibitory concentration of copper (MIC-Cu) was evaluated in
all the isolates; results revealed that a concentration as low as 250 ppm copper was
able to inhibit the great majority of microorganisms analyzed (65% of isolates). The
remaining isolates showed a MIC-Cu between 375 and 700 ppm copper, and no growth
was observed at 1000 ppm. A linear relationship was found between the logarithm
of viable bacteria number and time of contact with copper. With the application of
the same concentration of copper (250 ppm), CNS showed the highest tolerance to
copper, followed by S. uberis and S. aureus; the least resistant was E. coli. Based on
these in vitro results, copper preparations could represent a good alternative to dipping
solutions, aimed at preventing the presence and multiplication of potentially pathogenic
microorganisms involved in bovine mastitis disease.
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INTRODUCTION
Bovine mastitis is an inflammatory disease of the mammary gland (Bradley, 2002; Thompson-
Crispi et al., 2014); it represents one of the main production and economic problems confronting
the global dairy industry (Zadoks and Fitzpatrick, 2009). The high costs associated with this
frequent pathology are derived from its impact on animal health and welfare and the profitability of
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milk sales (i.e., impacts on milk production level and milk
quality) (O’Grady and Doherty, 2009). International studies
estimate an average cost of U.S. $224-275 per case, resulting
in annual losses in the millions, including costs of antibiotic
treatments, veterinary care, milk withdrawal, labor, and milk
production losses (Steeneveld et al., 2011).
Bovine mastitis disease begins with the invasion and
colonization of microorganisms via the teat duct orifice, creating
inflammation in the mammary gland that results in a clear
productive decline and in unwanted physical and chemical
changes in the milk (De Vliegher et al., 2012; Thompson-
Crispi et al., 2014). Staphylococcus aureus, Escherichia coli, and
Streptococcus uberis are frequently found in clinical mastitis (De
Vliegher et al., 2012). Intramammary bacterial infections are the
principal causes of clinical and subclinical mastitis (De Vliegher
et al., 2012).
The clinical manifestation is characterized by physical
alterations of the gland; this in turn deteriorates milk quality and
reduces its volume (Cha et al., 2011). In contrast, in subclinical
mastitis the visual symptoms and signs are absent, but the milk
shows elevated somatic cell counts (SCCs) (Halasa et al., 2009;
De Vliegher et al., 2012), which reduces the value of the milk.
In addition, subclinical mastitis may also cause infection by
spreading the bacteria among farms and even between animal
species.
The National Institute for Research in Dairying (NIRD)
program includes different strategies for mastitis control
management such as dry cow treatment, milking techniques,
teat disinfection with topical antiseptic substances (pre-dipping
and dipping) and antibiotic treatment of clinical mastitis cases
(Barkema et al., 1998; Nickerson, 2009). However, antiseptic
substances routinely used in dairy production such as iodine
or chlorhexidine are not completely effective in reducing or
preventing mastitis (Drechsler et al., 1993; El Behiry et al.,
2012).
The use of antibiotics, confined to selected severe cases,
requires bacterial isolation and antibiotic selection (Roberson,
2012). In addition, the routine use of antibiotics is questionable
because their use can generate unwanted residues not accepted
in milk, and because they can spread the emergence of
antimicrobial-resistant strains (Gao et al., 2012; Oliver and
Murinda, 2012; Wang et al., 2012; Nosanchuk et al., 2014). Since
bovine mastitis remains a worldwide problem, producers and
governments continue searching for a non-antibiotic solution or
technologies to reduce the prevalence of the disease (Cheng et al.,
2014).
Finding successful strategies for the control of bovine mastitis
is a challenge for dairy producers. Currently the programs
are based on hygiene and include teat disinfection, antibiotic
therapy and culling of chronically infected cows. The search
for alternatives to antibiotics (i.e., bacteriophages, vaccines,
or natural compounds) is a field being explored to find an
effective approach for management of bovine mastitis (Gomes
and Henriques, 2016). One alternative to be used as an effective
teat disinfection may be a copper-based product.
The use of antimicrobial copper was accepted for the first
time in 2008 by the United States Environmental Protection
Agency (EPA, 2008)1. Studies showed that copper surfaces can
eliminate bacteria (i.e., S. aureus, Enterobacter aerogenes, MRSA,
Pseudomonas aeruginosa, and E. coli O157:H7) usually causing
nosocomial infections. Lately, the efficacy of copper has been
tested in other microorganisms such as viruses, fungi, and other
bacterial pathogens (Faúndez et al., 2004; Wilks et al., 2005; Noyce
et al., 2006; Grass et al., 2011).
Copper antibacterial functionality is associated with various
mechanisms, including damaging the microbial DNA, altering
bacterial protein synthesis and altering membrane integrity
(Warnes et al., 2010; Grass et al., 2011; Chaturvedi and
Henderson, 2014). In addition, the antibacterial effect of copper
was already proved for E. coli and S. aureus, two of the main
bacterial species involved in mastitis (Noyce et al., 2006; Espírito
Santo et al., 2011).
The aim of the present study was to evaluate in vitro the
antimicrobial activity of copper on microorganisms isolated from
bovine mastitis. Microorganisms were isolated from milk samples
of animals with bovine mastitis (clinical and subclinical). Samples
were from two geographic areas of Chile (central and southern
regions) with different production systems between March and
September, 2013.
MATERIALS AND METHODS
Sampling and Bacterial Identification
We analyzed 386 samples of raw milk from clinical and
subclinical bovine mastitis that were collected between March
and September 2013 in two geographical regions of Chile (central
and southern). A total of sixteen dairy farms were included in the
sampling, six from the central region and ten from the southern
region (Figure 1). The selected cows were previously diagnosis
with clinical or subclinical bovine mastitis and the sampling
conducted during regular milking times.
Ethical approval was not required for milk sampling,
because this study was carried out in accordance with the
routinely milking procedures, which was supervised by official
veterinarians. Subclinical and clinical bovine mastitis were
defined according to Schukken et al. (2003). In subclinical
mastitis, the SCC was greater than 200,000 cells per milliliter of
milk. In the case of clinical mastitis, in addition to high SCC
the milk presented evident organoleptic changes, such as the
presence of clots and yellow color, among others, which were
visually inspected.
Tested animals were under a regular disinfection protocol
using iodine as teat dip before milking. Milk samples from each
teat were collected aseptically according to the NMC protocol,
placed into sterile tubes and transported on the same day under
cooling conditions to the laboratory. Bacteriological culture of
milk samples and bacterial identification were performed as
recommended by the National Mastitis Council.
The collected milk samples were centrifuged at 2500 × g
for 5 min and the pellet was cultured on different agar media:
1http://gochemless.com/pdf/EPA_Registers_Copper_Containing_Alloy_
Products.pdf
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FIGURE 1 | Location in Chile of dairy farms sampled (López, 2014).
Chile is divided into 15 Regions, each one is identified by a Roman numeral
(I to XV). Regions sampled during the study are enclosed in circles.
5% sheep blood agar plates, McConkey agar plates (Oxoid Ltd,
Basingstoke, Hampshire, England), tryptic soy agar plates (BBL,
Becton Dickinson, USA) and Sabouraud dextrose agar. Ten
micro liter of pellet were streaked per agar plate. The agar plates
were incubated at 37◦C for 18–24 h; those with no growth were
left up to 48 h. The results obtained in the culture medium were
interpreted and recorded according to the following criteria: (a)
positive culture: growth of five or more colonies of the same
type or two types of colony with a minimum eight colonies per
type. (b) Negative culture: no growth or growth of less than
five colonies of the same type. (c) Contaminated sample: growth
of three or more different types of colonies. Isolates were sub-
cultured to obtain pure cultures. The identification of bacteria
was performed according to colony morphology, Gram staining,
and biochemical tests.
Phenotypic differentiation of bacterial species was conducted
as follows: Staphylococci and Streptococci were identified
presumptively based on colony morphology, Gram stain
and catalase test. Coagulase-positive Staphylococci (S. aureus,
Staphylococcus intermedius, and Staphylococcus hyicus) were
identified based on morphology, pigmentation, coagulase test,
Voges Proskauer, and the ONPG test (Capurro et al., 1999).
Specific polymerase chain reaction (PCR) tests were used to
confirm S. aureus strains using primers NUC1 and NUC2
described by (Gandra et al., 2011) (Supplementary Figure S1A).
All coagulase-negative Staphylococci were considered as CNS
(coagulase-negative Staphylococci) after showing resistance to
bacitracin (0.04U). The Staphylococci sensitive to bacitracin
(0.04U) were considered as Micrococcus spp. (Falk and Guering,
1983). Streptococcus species were differentiated based on
hemolysis, esculin, CAMP and the inulin test. S. uberis was
confirmed by PCR with oligonucleotide primers designed for the
16S rRNA gene (Hassan et al., 2001) (Supplementary Figure
S1B).
Corynebacterium spp. were identified presumptively based on
colony morphology, hemolysis, esculin, and the API R© Coryne test
(Biomerieux). Results were confirmed by PCR amplification of
the rpoB gene (Khamis et al., 2004) (Supplementary Figure S1C).
Yeasts and Enterobacteriaceae were presumptively identified
based on colony morphology, Gram stain and API R© 20C
Aux (Biomerieux) for yeasts and API R© 20E (Biomerieux) for
Enterobacteriaceae. E. coli was confirmed by PCR amplification
of the uspA gene (Chen and Griffiths, 1998) (Supplementary
Figure S1D). All isolates were stored at−80◦C until further use.
Antimicrobial Susceptibility Testing
The antimicrobial susceptibility tests included six antibiotics:
amoxicillin/clavulanic Acid (AMC) 20/10 µg (BBL, Becton
Dickinson, USA), sulphamethoxazole/trimethoprim (SXT)
25 µg (Oxoid Ltd., Basingstoke, Hampshire, England),
cefotaxime (CTX) 30 µg (BBL, Becton Dickinson, USA),
tetracycline (TET) 30 µg (BBL, Becton Dickinson, USA),
gentamicin (GN) 10 µg (BBL, Becton Dickinson, USA), and
neomycin (NE) 30 µg, (Oxoid Ltd., Basingstoke, Hampshire,
England).
The susceptibility to antibiotics was tested against all bacterial
isolates (n = 324) using the diffusion test proposed by Kirby–
Bauer following the recommendations of the Clinical Laboratory
Standards Institute guidelines (Clinical Laboratory Standards
Institute [CLSI], 2012b) and the BSAC guide (Andrews and
BSAC Working Party on Susceptibility Testing, 2008). In this
analysis only the three Candida spp. were excluded. Organisms
were incubated on Mueller Hinton (MH) agar plates at 35◦C
for 18–24 h in aerobic atmosphere. E. coli (ATCC-25922) and
S. aureus (ATCC-25923) were used as quality control. The CLSI
breakpoints were used for the interpretation of susceptibility
to all microbial agents. The BSAC standard was applied to
determine the breakpoint value of Neomycin (NE).
Determination of Minimum Inhibitory
Concentration of Copper (MIC-Cu)
The minimum inhibitory concentration of copper (MIC-Cu)
was determined by the agar dilution method against 327
microorganisms isolated, applying standard bacteriological
methods (Clinical Laboratory Standards Institute [CLSI],
2012a). Briefly, MH agar plates were supplemented with
seven concentrations of copper (II) sulfate pentahydrate
(CuSO4x5H2O) (Merck Millipore, Germany): 50, 125, 250,
375, 500, 750, and 1000 ppm of copper. Overnight culture of
each microorganism was diluted to 1x106 CFU/ml; 5 µL of this
dilution was inoculated as spots with a microplate replicator.
Each assay was performed in triplicate. The MIC-Cu was defined
as the lowest concentration of copper at which no growth was
observed following overnight incubation at 37◦C.
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Inactivation of Microorganisms by
Copper
The antibacterial effect of copper over time was evaluated in
the four most prevalent strains [coagulase-negative Staphylococci
(CNS) (MT-163), E. coli (Al-563), S. aureus (MT-359), and
S. uberis (MT-360)] isolated from milk with clinical bovine
mastitis. For this, an overnight culture for each bacteria was
refreshed and grown until it reached an optical density of 1.0
(600 nm) in TSAYE broth (BBL, Becton Dickinson, USA) at 37◦C.
For the inactivation treatment, the same concentration of MIC-
Cu for each microorganism (previously stated) and double the
MIC-Cu were prepared in phosphate buffered saline PBS buffer
(pH = 7.0) and inoculated with the above refreshed culture with
concentration ca. 107–108 CFU/ml.
One-hundred micro liter of the suspension were taken at 0, 15,
30, 60, and 90 min after copper exposition and mixed with 900 µl
of sterile PBS to stop the effect of the copper. One-hundred micro
liter of this dilution as well as the same volume of serial dilutions
were seeded in TSAYE agar and incubated at 37◦C for 24 h for
survivor counting. Experiments were performed in triplicate and
sterile PBS was used as control medium.
Statistical Analysis
To evaluate the significant relationships between species of
microorganisms isolated and geographical region, we used the
two sample proportion test (Stata V11.0). The level of significance
used was p< 0.05.
The Dc value, defined as the time (min) required to decrease
the microbial population by 1 log CFU/ml at a specific copper
concentration, was calculated for all the assayed conditions
mentioned in the previous section. For this purpose, the decimal
logarithm of the number of survivors was plotted versus the
time (min) to obtain the survival curves for each experimental
condition. The curves were fitted using the freeware tool GInaFiT
Add-In Microsoft Excel (Geeraerd et al., 2005). The Dc values
were calculated from the inactivation rate (kmax) from the best
fit provided by GInaFiT (Dc = 2.303/kmax). A one way ANOVA
was conducted to compare Dc values. ANOVA assumptions were
evaluated using the Bartlett test (Zar, 1999) with StatGraphics
Plus 5.0.
RESULTS
Microorganisms Isolated from Bovine
Mastitis
A total of 386 milk samples were collected, 274 from the southern
region where 199 milk samples presented signs of subclininal
mastitis and 75 of clinical mastitis. In the central region 112
samples were collected, 49 with subclinical mastitis and 63
samples with clinical mastitis.
According to the microbiological analysis of samples, the milk
from cattle with mastitis was negative in 123 samples (32%); nine
samples were excluded for contamination with three or more
microorganisms. Of the remaining samples (n = 254) a total of
327 microorganisms were isolated (Figure 2); three of them were
identified as Candida spp. from subclinical mastitis (one from
the central region and two from the southern region). Different
bacterial species were identified; the distribution related to the
origin and the types of mastitis is shown in Figure 2.
In animals from the central region, CNS, Corynebacterium
spp. and S. uberis were the most frequent agents detected
in subclinical mastitis samples; 13 (31%), 10 (22%), and 7
(17%), respectively (Figure 2A). In the animals with clinical
mastitis, E. coli and CNS (33%) were the agents most frequently
identified (Figure 2B). For the samples from the southern region,
S. aureus, CNS, and S. uberis were the most frequent bacteria,
from both clinical and subclinical mastitis (Figures 2C,D). It
can be observed in the same figure that E. coli was identified
only in the central region with 4 and 33% in subclinical and
clinical bovine mastitis, respectively. In addition, S. aureus
had greater presence in the southern region, with 30 and
21% in subclinical and clinical subclinical bovine mastitis,
respectively.
The frequency of S. uberis isolation was greater in the southern
sample than in the central region (22 versus 5%, respectively)
in milk samples from clinical bovine mastitis; however, in
subclinical samples it was slightly greater in the central region
with 17% than in the southern region with 13%. Other bacteria
such as Corynebacterium spp. isolates were also identified in
samples with frequencies of 22 and 15% in the central regions
and 4 and 7% in the southern region from subclinical and clinical
mastitis, respectively.
In order to find potential strategies to control bovine mastitis
we evaluated the susceptibility of all microorganisms isolated to
antibiotics and to copper.
Antibiotic Susceptibility
Antibiotic susceptibility was evaluated for 324 bacteria isolated
(Candida spp. were excluded, since antifungal agents were not
tested). The results of the susceptibility testing showed that
215 out of 324 (66%) isolates were sensitive to all antibiotics
tested. A larger number of these susceptible isolates belonged to
cows with subclinical mastitis (n = 140 isolates). The frequency
of antimicrobial susceptibility to antibiotics is presented in
Supplementary Figure S2. We conclude that in the central
region, the antibiotics CTX, AMC, TET, and NE presented
a resistance percentage greater than 10% in the isolates with
clinical mastitis (intermediate and resistant). The AMC, NE,
and GN antibiotics showed similar results in the isolates
obtained in bovines with clinical mastitis from the southern
region.
The results of antibiotic susceptibility for microorganisms
with higher frequency of isolation in bovines with clinical
mastitis showed that E. coli isolated from the central region
had a variable frequency of resistance to the different antibiotics
tested (Table 1). In particular, 7/13 (54%) isolates showed
resistance to NE. S. uberis isolated from the southern region
showed a high percentage of resistance to aminoglycosides GN
and NE (47 and 58%). Some S. uberis were also resistant
to CTX (26%). S. aureus and CNS isolates presented a
low frequency of resistance to almost all antibiotics tested
(Table 1).
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FIGURE 2 | Bacterial species distribution isolated from milk samples. Microorganisms identified in subclinical (A, central; C, southern) and clinical (B, central;
D, southern) mastitis milk samples. The central region includes 82 isolates and the southern region includes 245 isolates. The label “Others” includes
microorganisms isolated with frequency ≤2% of the total. # indicate that the frequency of isolation of microorganisms, from subclinical mastitis, between the regions
is significantly different (p ≤ 0.05). ∗ indicate that the frequency of isolation of microorganisms, from clinical mastitis, between the regions is significantly different
(p ≤ 0.05). Others included: Enterobacter cloacae, Enterococcus faecium, Streptococcus spp., Bacillus, non-fermenting Bacillus, Aeromona, Yersinia sp., Serratia
sp., and Candida spp.
TABLE 1 | Percentage of antibiotic resistance for the most frequently identified isolates from clinical bovine mastitis milk samples.
Central region South region
Resistance to Escherichia coli CNS Staphylococcus aureus Streptococcus uberis CNS
(n:13) (n:13) (n:18) (n:19) (n:16)
GN 15.4% 0 0 47.4% 0
NE 53.8% 15.4% 5.6% 57.9% 6.3%
CTX 15.4% 0 0 26.3% 6.3%
AMC 23.1% 0 0 0 0
TET 23.1% 7.7% 0 0 0
SXT 15.4% 0 0 0 0
Activity of Antimicrobial Copper
To assess the antimicrobial activity of copper, MIC-Cu was
evaluated for all microorganisms isolated from milk with
clinical and subclinical bovine mastitis. The results showed
(Supplementary Figure S3) that a majority of isolates from
clinical and subclinical samples were inhibited by 125 ppm
or less copper (90/327) and 250 ppm of copper (122/327);
however, there were two isolates that required 700 ppm [Candida
spp. (subclinical) in the central region and Streptococcus spp.
(clinical) in the southern region]. No growth was observed
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for any microorganism at 1000 ppm. Subclinical isolates
showed slightly lower MIC-Cu values than those observed
for clinical mastitis isolates in both regions sampled. The
different behavior of bacteria species to MIC-Cu was apparently
not related to origin (central or southern region) of milk
samples (Supplementary Figure S3); in both cases nearly
93% of isolates were inhibited with less than 500 ppm of
copper.
The results for the bacteria identified most frequently in
clinical mastitis showed that 250 ppm of copper inhibited 77
and 62% of isolates of E. coli and CNS from the central region,
respectively (Figure 3A), likewise, S. aureus, CNS, and S. uberis
isolates (Figure 3B) from the southern region were inhibited 39,
50, and 63%, respectively (clinical mastitis). At 500 ppm copper
all the isolates were completely inhibited (Figure 3).
Figure 4 shows the inactivation curves of four strains
belonging to the four most frequent pathogenic species which
were isolated from clinical mastitis [E. coli (Al-563), CNS (MT-
163), S. aureus (MT-359), and S. uberis (MT-360)]. It was
observed that with less than 60 min of exposure to a copper
concentration of 250 ppm E. coli, S. aureus, and S. uberis reduced
their viability by almost 7 log CFU/ml, while CNS reduced its
viability ca. 7 log CFU/ml after 60 min when it was exposed
to 500 ppm of copper. The selected E. coli strain was the most
susceptible to copper.
A log linear relationship was found between the logarithm
of viable bacteria number and time of inactivation. A log-linear
model (equations in Figure 4) of the experimental data resulted
in high coefficients of determination (R2 > 0.90).
The Dc values are shown in Table 2. It can be observed that for
the same intensity of stress (250 ppm Cu), E. coli (Dc = 4.6 min)
was the least resistant, followed by S. aureus (Dc= 6.37 min) and
S. uberis (Dc = 11.71 min). CNS showed the highest resistance
value (Dc = 14.64 min), meaning that it needs a longer time to
reduce the population by 1 log.
The within-strain comparisons (Table 2) for different
intensities of stress (ppm copper) showed that the Dc values were
significantly different in all cases (p< 0.05). Comparison between
strains subjected to the same concentration of copper showed that
the Dc values of E. coli and S. aureus (125 and 250 ppm) were
not significantly different (p > 0.05). The Dc value for 500 ppm
copper in CNS was not significantly different from the Dc value
of 125 ppm for E. coli and S. aureus.
DISCUSSION
Bovine mastitis is a serious problem for dairy production
worldwide. In this study we evaluated in vitro the antimicrobial
effectiveness of copper solutions to inactivate microorganisms
prevailing in bovine mastitis. The results showed that the
prevailing agents are related to the geographical region. One
study reported by Kalmus et al. (2011) indicated that S. uberis and
E. coli are the main pathogens associated with clinical mastitis
in Estonia. However, in Sweden S. aureus has high prevalence
(21.3%) causing this pathology (Ericsson Unnerstad et al., 2009).
In India, cows with subclinical mastitis showed a highly variable
TABLE 2 | Dc values (min) for strains isolated from clinical bovine mastitis
exposed to different copper concentrations.
Dc values (min)
Copper (ppm)
125 250 500
E. coli 9.21a (0.03) 4.6c (0.04) –
CNS – 14.64d (0.012) 9.6a (0.01)
S. aureus 9.91a (0.01) 6.37c (0.03) –
S. uberis 23.47b (0.01) 11.71d (0.02) –
a,b,c,dThe same letter indicates no significant difference (p > 0.05) under the same
copper concentration. Values in brackets are standard error.
microbiota. Metagenomic analysis of the affected milk revealed
that E. coli was the predominant microorganism in two cattle
breeds studied, while S. aureus stood out in a third breed (Bhatt
et al., 2012).
The present study explored the current frequency and
diversity of pathogens involved in bovine mastitis in two
geographical regions of Chile. The isolation frequency of E. coli
was high in the central region, probably due to the permanent
confinement system applied in this region. S. aureus was
more frequently identified in the southern region where a free
pasturage system prevails, as previously described (San Martin
et al., 2002). These authors reported a similar prevalence of
S. uberis in the two regions (near 3%). In contrast, in our study the
frequency of detection of S. uberiswas higher (22% clinical bovine
mastitis) in the southern region under pasture feeding (Figure 2).
These differences may imply that the etiology of bovine mastitis
in Chile has undergone modification after 10 years. This change
could be related to the type of feeding, the use of antibiotic
therapy, environmental modifications or other factors as have
been described in other countries (Zadoks and Fitzpatrick, 2009).
The use of antibiotics is frequent in the dairy industry to
control bacteria-causing bovine mastitis (Oliver and Murinda,
2012; Royster and Wagner, 2015). Antibiotic-resistant bacteria
can be favored as a result, becoming a serious problem for
dairy farms. A number of studies have been undertaken to
determine the frequency of antibiotic resistance in bovine
mastitis (Tenhagen et al., 2006; Bengtsson et al., 2009; Oliver
and Murinda, 2012; Saini et al., 2012b; Rato et al., 2013). In our
study we also evaluated the antibiotic susceptibility of isolated
microorganisms to antibiotics commonly used against bovine
mastitis (Supplementary Figure S2). The results showed that
on average 34% of the strains isolated were resistant to at least
one antibiotic evaluated. In particular, E. coli isolates showed
the highest resistance rate for almost all antibiotics tested. In
addition, 69% of E. coli from the central region and clinical
bovine mastitis strains were resistant to one or more antibiotics;
similar results were recently reported (Saini et al., 2012a). In the
current study many bacterial isolates showed resistance against
neomycin (63/324; 19%); this antibiotic is commonly used as an
intramammary antiseptic to treat bovine mastitis in Chile.
The use of iodine as teat dip is common in the national and
international dairy industry; the main advantage being the low
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cost and the strong color that the product stains the nipple.
However, the inactivation of iodine in the presence of organic
matter and the limited efficacy are two negative characteristics of
this product (Galton et al., 1984).
The use of copper as an alternative to prevent bovine mastitis
appears as a novel and promising idea. Several reports confirm
the antimicrobial potential of copper on various pathogens
that cause nosocomial disease in humans (Warnes et al., 2010;
Zhu et al., 2012). Our results show that a concentration as
low as 250 ppm of copper inhibited bacterial growth in 65%
of the isolates from bovine mastitis, including bacteria with
a wide pattern of antibiotic resistance isolated from clinical
mastitis (Figure 3). In addition, a higher copper concentration
of 1000 ppm should ensure inactivation, meaning it prevents
the multiplication of all the microorganisms involved in bovine
mastitis (Supplementary Figure S3). Upton (1988) patented a
method that proposed to control bovine mastitis by applying
a solution of an organic compound containing a low copper
concentration (50 ppm). His method was tested on only two
bacterial species. In our study, we tested copper antimicrobial
activity on eight different bacterial genera and yeasts (see
Supplementary Figure S3 and Figure 3).
In terms of the potential for cross-resistance between copper
and clinical antibiotics, Cavaco et al. (2011) showed that the MIC
of copper sulfate was not associated with methicillin resistance
S. aureus. Similarly, we have not observed particularly high
values of MIC-Cu for E. coli and S. uberis isolates (Figure 3).
These species showed a higher percentage of strains resistant
to antibiotics compared to the other species most frequently
isolated from clinical bovine mastitis (Table 1). Yazdankhah et al.
(2014) presented a review of different publications regarding
susceptibility of copper and the profile of antibiotic susceptibility;
the authors indicated that more evidence is necessary to clarify
the link between copper tolerance and antibiotics resistance
(Yazdankhah et al., 2014).
The four strains representing the species of microorganisms
identified most frequently in clinical mastitis showed some
variability in the response to the different concentrations of
copper applied (Figure 4). Other studies have shown that there is
a large variability in the number of survivors during inactivation
(Aguirre et al., 2009; Aspridou and Koutsoumanis, 2015). This
variability can be affected by the inoculum size, which also
affects the inactivation time of the microorganism (Aspridou and
Koutsoumanis, 2015).
We also demonstrated for the selected strains that the
antibacterial effect of copper occurred in a short time (Table 2
and Figure 4), which is important to consider for whether
solutions containing this metal could be used as part of a
mixture for dipping to control bovine mastitis. MICs chosen
in this study allowed rapid inhibition of the strains of E. coli,
S. aureus, and S. uberis, however, the strain chosen for CNS
showed a slow decay. Koutsoumanis and Lianou (2013) showed
that there was significant strain variability in response to stress.
In our case it would be desirable to evaluate more strains
to assess the biological variability of this response. However,
in a practical scenario a concentration of 1000 ppm would
inhibit 99% of the entire microbial load according to the
results obtained with a Monte Carlo simulation (data not
shown).
Previous studies on the antimicrobial properties of metallic
copper surfaces have been reported; the effectiveness of different
contents of copper alloys, temperatures, and other parameters
have been also evaluated (Wilks et al., 2005; Michels et al., 2009).
Also, other studies described the inactivation kinetics of a wide
variety of microbes on copper surfaces (Mehtar et al., 2008;
Espírito Santo et al., 2010; Weaver et al., 2010). Copper ions and
oxidative stress play a role during contact of bacteria with copper
surfaces (contact killing), inducing membrane damage in cells
exposed to copper surfaces (Espírito Santo et al., 2008; Elguindi
et al., 2009; Molteni et al., 2010).
FIGURE 3 | Minimum inhibitory concentration of copper (MIC-Cu) value distribution for the most prevalent isolates from clinical bovine mastitis.
Isolates from: (A) central region and (B) southern region.
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FIGURE 4 | Inactivation curves of copper of four isolates from clinical mastitis: (A) Escherichia coli (Al-563), (B) CNS (MT-163), (C) S. aureus (MT-359),
and (D) S. uberis (MT-360). The isolates were exposed to different concentrations of copper. Bacterial counts were analyzed by CFU assay. Each determination
was made in triplicate.
CONCLUSION
This study shows that copper inhibits bacterial multiplication
of different species isolated from bovine mastitis, and it may be
an attractive alternative to apply as a teat dip to control bovine
mastitis in milk farms. A copper concentration of 1000 ppm
inhibited almost all bacterial growth. However, further studies
are needed to assess the microbial response to copper in vivo. The
biological variability of individual bacterial cells and strains needs
to be identified to optimize the copper concentration required to
inhibit bacterial growth. The results of this study will be useful for
developing a quantitative microbial risk assessment.
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FIGURE S1 | Polymerase chain reaction (PCR) amplification for
confirmation of different bacterial species. (A) S. aureus, (B) S. uberis, (C)
Corynebacterium sp., and (D) E. coli.
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FIGURE S2 | Frequency of antimicrobial susceptibility of bacteria isolated
from the central region (A, n = 41; B, n = 40) and the southern region (C,
n = 157; D, n = 86) of subclinical and clinical bovine mastitis, respectively.
White bars are susceptible, gray bars are intermediate and black bars resistant
bacteria. Breakpoints (susceptible, intermediate, and resistant) were defined
according to CLSI.
FIGURE S3 | Frequency of MIC-Cu values for microorganisms isolated
from milk samples obtained from: (A) Central region (40 clinical and 42
subclinical mastitis) and (B) Southern region (86 clinical and 159
subclinical mastitis). Gray bars represent the frequency of microorganism
isolated from subclinical mastitis and black bars are from clinical mastitis. Each
determination was performed in triplicate.
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